BioNTech's Chinese partner Shanghai Fosun Pharmaceutical Group plans to import 7.2 million doses of the German company's COVID-19 vaccine in the first half of 2021, Caixin learned from several people familiar with the company's plan.
Company working with airlines to start shipments in January
Fosun is arranging logistics with several airlines to start transporting the vaccine from BioNTech’s German factory to China starting in January. © Reuters
BioNTech's Chinese partner Shanghai Fosun Pharmaceutical Group plans to import 7.2 million doses of the German company's COVID-19 vaccine in the first half of 2021, Caixin learned from several people familiar with the company's plan.